New Maintenance Option Approved for Asthma
Summary
Breztri becomes the first single-inhaler triple therapy for patients as young as 12 years
Description
Breztri becomes the first single-inhaler triple therapy for patients as young as 12 years
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source